Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
NPAS3-regulated astrocyte mitochondrial bioenergetics is required for cognition.
Journal: Science advances
Published: June 17, 2026
Ultra-Treatment-Resistant Schizophrenia: Unmet Needs and a Critical Opportunity for Discovery.
Journal: Schizophrenia bulletin
Published: May 15, 2026
Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of life.
Journal: Journal of psychiatric research
Published: February 23, 2026
Substantia nigra pars reticulata involvement in auditory hallucinations of treatment-resistant schizophrenia: a deep brain stimulation case report.
Journal: Schizophrenia (Heidelberg, Germany)
Published: September 29, 2025
Qualitative analysis of long-term clozapine adherence in schizophrenia: An exploratory study.
Journal: Psychiatry research
Published: September 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine Utilization.
Journal: Schizophrenia bulletin
Published: June 15, 2025
Clozapine as a Long-Term Therapeutic Choice: Longitudinal Analysis of Schizophrenia Symptoms in a Naturalistic Setting.
Journal: Schizophrenia bulletin open
Published: June 10, 2025
Functional Evidence for Substantia Nigra Pars Reticulata Involvement in Auditory Verbal Hallucinations in Treatment-Resistant Schizophrenia.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.
Journal: Journal of clinical psychopharmacology
Published: April 08, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.
Journal: Journal of clinical psychopharmacology
Published: April 08, 2025
The nuclear export signal mediates mutant atrophin-1-induced neuropathology in a mouse model of DRPLA.
Journal: Human molecular genetics
Published: January 13, 2025
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated?
Journal: Schizophrenia research
Published: June 01, 2024
Last Updated: 09/26/2026